Profilo
Arnold S.
Lippa was the founder of Patch International, Inc. (1984), serving as President & Chief Operating Officer from 1984 to 1994.
Dr. Lippa was the founder of DOV Pharmaceutical, Inc. (1995), serving as Director from 2005 to 2006.
Dr. Lippa is the founder of Atypical BioVentures Fund, LLC (2004), serving as Manager since 2004.
Dr. Lippa is the founder of Atypical BioCapital Management LLC (2004), serving as Manager since 2004.
Dr. Lippa is the founder of T.
Morgen Capital LLC (2005), serving as Senior Managing Director since 2005.
Dr. Lippa is the founder of Xintria Pharmaceutical Corp.
(2006), serving as Executive Chairman since 2015.
Current jobs include Executive Chairman, President & CEO at RespireRx Pharmaceuticals, Inc. since 2022, and President at Aurora Capital LLC since 2005.
Former jobs include Director-Molecular Neurobiology at Wyeth Holdings LLC, Independent Director at Hepion Pharmaceuticals, Inc. from 2015 to 2023, Professor at City University of New York, and Professor at New York University School of Medicine.
Posizioni attive di Arnold Lippa
| Società | Posizione | Inizio |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Amministratore Delegato | 31/01/2022 |
Xintria Pharmaceutical Corp. | Fondatore | 01/01/2006 |
Aurora Capital LLC
Aurora Capital LLC Investment Banks/BrokersFinance Provides investment banking services | Presidente | - |
Atypical BioCapital Management LLC | Fondatore | 01/01/2004 |
T. Morgen Capital LLC | Fondatore | 01/01/2005 |
Atypical BioVentures Fund, LLC | Fondatore | 01/01/2004 |
Precedenti posizioni note di Arnold Lippa
| Società | Posizione | Fine |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 22/06/2023 |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Amministratore Delegato | 01/01/2006 |
Patch International, Inc.
Patch International, Inc. Contract DrillingIndustrial Services Develops and explores oil sands | Fondatore | 01/01/1994 |
| ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
RespireRx Pharmaceuticals, Inc.
RespireRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that discovers and develops drug therapies for the treatment of sleep apnea, respiratory depression & other brain-mediated breathing disorders | Health Technology |
Patch International, Inc.
Patch International, Inc. Contract DrillingIndustrial Services Develops and explores oil sands | Industrial Services |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Commercial Services |
Aurora Capital LLC
Aurora Capital LLC Investment Banks/BrokersFinance Provides investment banking services | Finance |
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
City University of New York
City University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atypical BioVentures Fund, LLC | |
T. Morgen Capital LLC | |
Xintria Pharmaceutical Corp. | |
Atypical BioCapital Management LLC | |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















